vilazodone

Known as: Vilazodonum, Vilazodona, 5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}benzofuran-2-carboxamide 
A selective serotonin (5-HT) reuptake inhibitor (SSRI) and a 5-HT-1A receptor partial agonist, with antidepressant and anti-anxiety activities… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
INTRODUCTION Vilazodone is a potent serotonin (5-HT) reuptake inhibitor and 5-HT₁A receptor partial agonist approved by the US… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2014
2014
PURPOSE Vilazodone is a serotonin reuptake inhibitor and 5-HT1A partial agonist approved for the treatment of major depressive… (More)
Is this relevant?
2013
2013
INTRODUCTION   Sexual dysfunction is common in major depressive disorder (MDD), and many serotonergic antidepressants adversely… (More)
  • table 1
  • table 2
  • table 4
  • table 5
  • table 8
Is this relevant?
2011
2011
Vilazodone, a selective serotonin (5-HT) reuptake inhibitor and 5-HT(1A) receptor partial agonist, was efficacious in two 8-week… (More)
Is this relevant?
Review
2011
Review
2011
Vilazodone, a novel antidepressant agent that combines selective serotonin reuptake inhibitor (SSRI) activity and serotonin 5-HT… (More)
  • table 2
Is this relevant?
2011
2011
OBJECTIVE To evaluate the efficacy, and further establish the safety profile, of oral once-daily vilazodone, a potent and… (More)
Is this relevant?
Review
2009
Review
2009
Vilazodone (EMD 68843; 5-{4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl}-benzofuran-2-carboxamide hydrochloride) is a combined… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
OBJECTIVE The efficacy and tolerability of vilazodone, a combined selective serotonin reuptake inhibitor and partial 5… (More)
Is this relevant?
Review
2007
Review
2007
Vilazodone is a combined selective serotonin reuptake inhibitor (SSRI) and a 5-HT(1A) receptor partial agonist that is being… (More)
Is this relevant?
2005
2005
Vilazodone has been reported to be an inhibitor of 5-hydoxytryptamine (5-HT) reuptake and a partial agonist at 5-HT1A receptors… (More)
Is this relevant?